2026 CPHI& The PMEC Pharmaceutical Industry Exhibition (Shenzhen) will grandly kick off from September 16th to 18th at the Shenzhen Convention and Exhibition Center (Futian). As an industry IP that has been deeply involved in domestic pharmaceutical exhibitions for more than 20 years, this is the second event of the exhibition landing in Shenzhen. Based on the advantages of the biopharmaceutical industry in the Guangdong Hong Kong Macao Greater Bay Area, it comprehensively showcases the innovative ecology of the pharmaceutical industry and creates a one-stop full industry chain business exchange platform CPHI in South China.

This exhibition covers an area of 30000 square meters and is expected to gather more than 800 domestic and foreign exhibitors. It will attract more than 15000 professional visitors from home and abroad, and hold more than 20 high-level industry forum activities at the same time. The exhibition revolves around the layout of the entire industry chain of source, research, production, and sales, and is divided into twelve exhibition sections including pharmaceutical raw materials, natural products, pharmaceutical machinery and packaging equipment, pharmaceutical excipients, biotechnology, medical beauty technology, clean engineering, laboratory instruments, etc., covering all aspects from drug research and development, production and manufacturing to finished product packaging.

In response to the trend of digital transformation in the domestic pharmaceutical industry, the exhibition is newly createdPharmaceutical digitization and pharmaceutical outsourcing services, intelligent manufacturingTwo distinctive thematic exhibition areas. We will showcase cutting-edge technological achievements such as AI drug development platforms, digital twin factories, intelligent production equipment, and pharmaceutical digital operation and maintenance systems, focusing on the practical needs of pharmaceutical companies to reduce costs and increase efficiency, and promote the deep integration of digital technology and pharmaceutical manufacturing.

Relying on the collaborative advantages of innovation between Shenzhen and Hong Kong, the exhibition will build a bridge for connecting domestic and foreign resources, introduce advanced production solutions for pharmaceutical enterprises in the Greater Bay Area, and promote the implementation and transformation of industry university research achievements. Multiple supporting forums will be held to discuss hot topics such as industrial policies, new drug research and development, intelligent manufacturing, and innovation of medical beauty raw materials, gathering industry experts and representatives of leading enterprises to discuss the future development direction of the industry.

The landing of this exhibition in Shenzhen will further activate the vitality of the South China biopharmaceutical industry and accelerate the intelligent and high-quality development process of the pharmaceutical industry in the Greater Bay Area.